Symptomtext
part of the medication combo was not administered (with no reported adverse event); Initial information received on 21-Apr-2022 regarding an unsolicited valid non-serious case received from Other Health Professional. This case involves a 2-month-old female patient for whom part of the medication combo was not administered (with no reported adverse event) while receiving vaccine diphtheria/tetanus/5 hybrid AC pertussis/IPV (MRC5)/HIB (PRP/T) vaccine [Pentacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included rotavirus vaccine (Rotavirus vaccine), hepatitis B vaccine (Hepatitis B vaccine), and pneumococcal vaccine CONJ13v (CRM197) (Prevnar 13), all for prophylactic vaccination. On 21-Apr-2022, the patient received the only DTAP/IPV portion of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine with unknown formulation, strength, (dose: 0.25 mL to 2 mL for vaccine) (lot UJ592AA, expiry date: 18-Dec-2022) via unknown route in the right thigh for Immunization. On 21-Apr-2022, physician gave the Dtap/IPV portion only of Pentacel to the patient and another part of the medication combo (ACT-HIB) was not administered (with no reported adverse event) (incorrect dose administered) (latency: same day). Action taken: Not applicable. It was not reported if the patient received a corrective treatment. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.